Senvest Management, LLC Gilead Sciences, Inc. Transaction History

Senvest Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $4.99 Million - $5.52 Million	-70,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $4.54 Million - $5.3 Million	70,000 New	70,000 $4.96 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $13.7 Million - $16.7 Million	-187,597 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $19.2 Million - $22.5 Million	-269,548 Reduced 58.96%	187,597 $13.4 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $33 Million - $39.1 Million	457,145	457,145 $37 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Senvest Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Senvest Management, LLC with notifications on news.